RSRCHXchange
-
U.S. to Study Effects of MiFID II Research Unbundling
U.S. lawmakers authorized a study focusing on the provision of investment research for small issuers, a sign they are wary of the U.S. adopting the European Union’s MIFID II unbundling rules which have brought sweeping changes to the research business.
-
FlexTrade Multi-Asset EMS Named Best Front-Office Execution System for Second Consecutive Year
FlexTrade today announced its FlexTRADER EMS has won, for the second consecutive year, the “Best Front-Office Execution System” category at the Financial News 2016 Awards for Excellence in Trading & Technology ceremony.
-
Impact of MiFID II: Unbundling, the Sell Side and Research Trends
European regulators are pressing to unbundle research payments from executions. Experts say that a regulatory overhaul driven by MiFID II has the potential to disrupt the global research industry. FlexTrade’s Ivy Schmerken examines further.
-
FlexTrade Partners with RSRCHXchange for MiFID II Compliance
Execution management system provider FlexTrade announced the integration of RSRCHXchange’s research database, which alerts traders to new research relevant to their activity. It will help clients comply with MiFID II’s unbundling requirements. FlexTrade’s Andy Mahoney comments.
-
FlexTrade to Offer Institutional Research to FlexTRADER EMS Users Via RSRCHXchange
FlexTrade today announced its partnership with RSRCHXchange to provide buy-side traders with immediate alerts to the availability of relevant research via the company’s FlexTRADER EMS.